Synuclein γ stimulates membrane-initiated estrogen signaling by chaperoning estrogen receptor (ER)-α36, a variant of ER-α

American Journal of Pathology

Volumn 177, Issue 2, 2010, Pages 964-973

  Shi, Yuenian Eric ^a,b   Chen, Yiding ^c   Dackour, Raduwan ^a   Potters, Louis ^a   Wang, Shui ^b   Ding, Qiang ^b   Wang, Zhaoyi ^d   Liu, Yiliang Ellie ^a  

^a FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^d CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA36; GAMMA SYNUCLEIN; HEAT SHOCK PROTEIN 90; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL GROWTH; CELL STIMULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HORMONE RESPONSE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; RECEPTOR DOWN REGULATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 77957266174     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.2353/ajpath.2010.100061     Document Type: Article

References (43)

1. Beato M: Gene regulation by steroid hormones. Cell 1989, 56:335-344
2. Norris JD, Fan D, Kerner SA, McDonnell DP: Identification of a third autonomous activation domain within the human estrogen receptor. Mol Endocrinol 1997, 11:747-754
3. Flouriot G, Brand H, Denger S, Metivier R, Kos M, Reid G, Sonntag-Buck V, Gannon F: Identification of a new isoform of the human estrogen receptor-alpha (hER-alpha) that is encoded by distinct transcripts and that is able to repress hER-alpha activation function 1. EMBO J 2000, 19:4688-46700
4. Penot G, Le Péron C, Mérot Y, Grimaud-Fanouillère E, Ferrière F, Boujrad N, Kah O, Saligaut C, Ducouret B, Métivier R, Flouriot G: The human estrogen receptor-alpha isoform hERalpha46 antagonizes the proliferative influence of hERalpha66 in MCF7 breast cancer cells. Endocrinology 2005, 146:5474-5484
5. Aronica SM, Kraus WL, Katzenellenbogen BS: Estrogen action via the cAMP signaling pathway: stimulation of adenylate cyclase and cAMP-regulated gene transcription. Proc Natl Acad Sci USA 1994, 91:8517-8521
6. Le Mellay V, Lasmoles F, Lieberherr M: Galpha(q/11) and gbeta-gamma proteins and membrane signaling of calcitriol and estradiol. J Cell Biochem 1999, 75:138-146
7. Razandi M, Pedram A, Greene GL, Levin ER: Cell membrane and nuclear estrogen receptors (ERs) originate from a single transcript: studies of ERalpha and ERbeta expressed in Chinese hamster ovary cells. Mol Endocrinol 1999, 33:307-319
8. Marquez DC, Pietras RJ: Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 2001, 20:5420-5430
9. Watters JJ, Campbell JS, Cunningham MJ, Krebs EG, Dorsa DM: Rapid membrane effects of steroids in neuroblastoma cells: effects of estrogen on mitogen activated protein kinase signaling cascade and c-fos immediate early gene transcription. Endocrinology 1997, 138:4030-4033
10. Pietras RJ, Szego CM: Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells. Nature 1977, 265:69-72
11. Revankar CM, Cimino DF, Sklar LA, Arterburn JB, Prossnitz ER: A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630
12. Driggers PH, Segars JH: Estrogen action and cytoplasmic signaling pathways. Part II: the role of growth factors and phosphorylation in estrogen signaling Trends Endocrinol Metab 2002, 13:422-427
13. Kelly MJ, Levin ER: Rapid actions of plasma membrane estrogen receptors. Trends Endocrinol Metab 2001, 12:152-156
14. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF: Identification, cloning, and expression of human estrogen receptor-alpha36, a novel variant of human estrogen receptor-alpha66. Biochem Biophys Res Commun 2005, 336:1023-1027
15. Wang Z, Zhang X, Shen P, Loggie BW, Chang Y, Deuel TF: A variant of estrogen receptor-{alpha}, hER-{alpha}36: transduction of estrogen- and antiestrogen-dependent membrane-initiated mitogenic signaling. Proc Natl Acad Sci USA 2006, 103:9063-9068
16. Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao G, Joseph BK, Rosen C, Shi YE: Identification of a breast cancer-specific gene. SNCG, by direct differential complementary DNA sequencing. Cancer Res 1997, 57:759-764
17. Clayton DF, George JM: The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease. Trends Neurosci 1998, 121:249-254
18. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL: Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 1997, 276:2045-2047
19. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jakes R, Goedert M: Alpha-synuclein in Lewy bodies. Nature 1997, 388:839-840
20. Jia T, Liu YE, Liu J and Shi YE: Stimulation of breast cancer invasion and metastasis by synuclein gamma. Cancer Res 1999, 59:742-747
21. Bruening W, Giasson BI, Klein-Szanto AJ, Lee VM, Trojanowski JQ, Godwin AK: Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary. Cancer 2000, 88:2154-2163
22. Wu K, Weng Z, Tao Q, Lin G, Wu X, Qian H, Zhang Y, Ding X, Jiang Y, Shi YE: Stage-specific expression of breast cancer-specific gene gamma synuclein. Cancer Epidemiol Biomarkers Prev 2003, 12:920-925
23. Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C, Wang L, Zhao W, Jiang JD, Liu J: Loss of epigenetic control of synuclein-gamma gene as a molecular indicator of metastasis in a wide range of human cancers. Cancer Res 2005, 65:7635-7643
24. Guo J, Shou C, Meng L, Jiang B, Dong B, Yao L, Xie Y, Zhang J, Chen Y, Budman DR, Shi YE: Neuronal protein synuclein gamma predicts poor clinical outcome in breast cancer. Int J Cancer 2007, 121:1296-1305 (Pubitemid 47293797)
25. Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao X, Chen Y, Budman D, Goldberg ID, Shi YE: Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis. Breast Cancer Res Treatment 2007, 101:259-267
26. Jiang Y, Liu YE, Lu A, Gupta A, Goldberg ID, Liu J, Shi YE: Stimulation of estrogen receptor signaling by gamma synuclein. Cancer Res 2003, 63:3899-3903
27. Jiang Y, Liu YE, Goldberg ID and Shi YE: γ synuclein, a novel heat-shock protein-associated chaperone, stimulates ligand-dependent estrogen receptor α signaling and mammary tumorigenesis. Cancer Res 2004, 64:4539-4546
28. Liu YE, Pu W, Jiang Y, Shi D, Dackour R, Shi YE: Chaperoning of estrogen receptor and induction of mammary gland proliferation by neuronal protein synuclein gamma. Oncogene 2007, 26:2115-2125
29. Gupta A, Inaba S, Wong OK, Fang G, Liu J: Breast cancer-specific gene 1 interacts with the mitotic checkpoint kinase BubR1. Oncogene 2003, 22:7593-7599
30. Inaba S, Li C, Shi YE, Song DQ, Jiang JD, Liu J: Synuclein gamma inhibits the mitotic checkpoint function and promotes chromosomal instability of breast cancer cells. Breast Cancer Res Treatment 2005, 94:25-35
31. Wullschleger S, Loewith R, Hall MN: mTOR signaling in growth and metabolism. Cell 2006, 124:471-484
32. Chang SB, Miron P, Miron A, Iglehart JD: Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells. J Surg Res 2007, 138:37-44
33. Yin XJ, Wang G, Khan-Dawood FS: Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines. Am J Obstet Gynecol 2007, 196:176.e1-5
34. Castro AF, Rebhun JF, Clark GJ, Quilliam LA: Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J Biol Chem 2003, 278:32493-32496
35. Prossnitz ER, Arterburn JB, Sklar LA: GPR30: A G protein-coupled receptor for estrogen. Mol Cell Endocrinol 2007, 265-266:138-142
36. Chambers AF: MDA-MB-435 and M14 cell lines: identical but not M14 melanoma? Cancer Res 2009, 69:5292-5293
37. Pratt WB, Toft DO: Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr Rev 1997, 18:306-360
38. Picard D, Khursheed B, Garabedian M, Fortin MG, Lindquist S, Yamamoto KR: Reduced levels of hsp90 compromise steroid receptor action in vivo. Nature 1990, 348:166-168
39. Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Sobue G: Alleviating neurodegeneration by an anticancer agent: an Hsp90 inhibitor (17-AAG). Ann NY Acad Sci 2006, 1086:21-34
40. Shi L, Dong B, Li Z, Lu Y, Ouyang T, Li J, Wang T, Fan Z, Fan T, Lin B, Wang Z, Xie Y: Expression of ER-α36, a novel variant of estrogen receptor α, and resistance to tamoxifen treatment in breast cancer. J Clin Oncol 2009, 27:3423-3429
41. Zou Y, Ding L, Coleman M, Wang Z: Estrogen receptor-alpha (ER-alpha) suppresses expression of its variant ER-alpha 36. FEBS Lett 2009, 583:1368-1374
42. Lee LMJ, Cao J, Chen P, Gatalica Z, Wang ZY: ER-α36, a novel variant of ER-a, is expressed in ER-α positive and negative human breast carcinomas. Anticancer Res 2008, 28:479-484
43. Solit DB, Basso AD, Olshen AB, Scher HI, Rosen N: Inhibition of heat shock protein 90 function down-regulates Akt kinase and sensitizes tumors to Taxol. Cancer Res 2003, 63:2139-2144